Luana Fianchi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Ejection Fraction

Top Venues

American journal of hematology

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Brunangelo Falini, Patrizia Chiusolo, Luana Fianchi, Livio Pagano
NPM1-mutated myeloid neoplasm with low percentage of blasts. American journal of hematology 99 (8) (2024)
Brunangelo Falini, Patrizia Chiusolo, Luana Fianchi, Livio Pagano
NPM1-mutated myeloid neoplasm with low percentage of blasts. American journal of hematology 99 (8) (2024)
Brunangelo Falini, Patrizia Chiusolo, Luana Fianchi, Livio Pagano
NPM1-mutated myeloid neoplasm with low percentage of blasts. American journal of hematology (2024)
Brunangelo Falini, Patrizia Chiusolo, Luana Fianchi, Livio Pagano
NPM1-mutated myeloid neoplasm with low percentage of blasts. American journal of hematology 99 (8) (2024)
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Dávila-Valls, Sonia Martin-Perez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Alessandra Iurlo, Jorge Labrador-Gomez, Raul Cordoba, Alberto López-García, Nicola Stefano Fracchiolla, Francesca Farina, Emanuele Ammatuna, Antonella Cingolani, Daniel García-Bordallo, Stefanie K Grafe, Yavuz M Bilgin, Michelina Dargenio, Tomás José González-López, Anna Guidetti, Tobias Lahmer, Esperanza Lavilla-Rubira, Gustavo-Adolfo Mendez, Lucia Prezioso, Martin Schönlein, Jaap A van Doesum, Dominik Wolf, Ditte Stampe Hersby, Ferenc Magyari, Jens Tomas Van Praet, Verena Petzer, Carlo Tascini, Iker Falces-Romero, Andreas Glenthoej, Oliver Andreas Cornely, Livio Pagano
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry. Journal of hematology & oncology 16 (1) (2023)
Luca Lanino, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Marta Riva, Angela Consagra, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Raffaele Palmieri, Antonella Poloni, Catello Califano, Isabella Capodanno, Federico Itri, Chiara Elena, Claudio Fozza, Fabrizio Pane, Anna Maria Pelizzari, Massimo Breccia, Francesco Di Bassiano, Elena Crisà, Dario Ferrero, Valentina Giai, Daniela Barraco, Antonella Vaccarino, Davide Griguolo, Paola Minetto, Martina Quintini, Stefania Paolini, Grazia Sanpaolo, Mariarosaria Sessa, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Livia Leuzzi, Angelo Genua, Attilio Guarini, Alfredo Molteni, Barbara Nicolino, Ubaldo Occhini, Giulia Rivoli, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Felicetto Ferrara, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Marco Frigeni, Rosaria Sancetta, Carmine Selleri, Ilaria Tanasi, Patrizia Tosi, Mauro Turrini, Laura Giordano, Carlo Finelli, Paolo Pasini, Ilaria Naldi, Valeria Santini, Matteo Giovanni Della Porta, null null
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. American journal of hematology (2023)
Francesco D'Alò, Ilaria Zangrilli, Elisa Cupelli, Luana Fianchi, Criscuolo Marianna, Giulia Falconi, Emiliano Fabiani, Livio Pagano, Stefan Hohaus, Valerio De Stefano
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome. Platelets 32 (3) (2020)